Clinical Trials

Melanoma

NCT07092410 2026-04-21

SuRage-EB

Phase 4 Withdrawn

Melanoma

NCT07504796 2026-04-21

ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

Phase 4 Recruiting

90 enrolled

Phase 4 Not yet recruiting

Melanoma

NCT03340506 2026-04-20

Dabrafenib and/or Trametinib Rollover Study

Phase 4 Recruiting

100 enrolled

CNSDermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Glioma, Lung Neoplasms, Melanoma

NCT07459543 2026-03-09

A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India

30 enrolled

Melanoma, Skin Neoplasms

NCT03673332 2026-01-22

EPITOP-01

Phase 4 Terminated

40 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT02626065 2025-09-15

PAIR

32 enrolled

Melanoma

NCT03715205 2025-08-29

Keynote-593

Phase 4 Not yet recruiting

150 enrolled 14 charts

DermatologicThoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Melanoma

NCT06785974 2025-01-22

SPIRAL

140 enrolled

Melanoma, Atherosclerosis

NCT01794793 2024-10-01

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

DermatologicEndocrineGenitourinaryNET

337 enrolled 8 charts

Acromegaly, Dumping Syndrome, Melanoma, Neoplasms, Pituitary Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors, Pituitary ACTH Hypersecretion

NCT06116461 2024-04-22

NIVOPTIMIZE

34 enrolled

Melanoma

NCT01856023 2023-12-05

PROCLIVITY02

Phase 4 Terminated

29 enrolled 9 charts

Melanoma, Neoplasm Metastasis, Skin Neoplasms

NCT03313544 2023-04-21

Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1

Phase 4 Active not recruiting

50 enrolled

DermatologicThoracic

Lung Neoplasms, Melanoma

NCT02068196 2023-03-24

Ipi4

150 enrolled

Melanoma, Neoplasms

NCT05467137 2022-07-20

MelanooMSOT

10 enrolled

Melanoma

NCT04074460 2022-06-09

VAPOR-C

BreastDermatologicGastrointestinalGenitourinaryThoracic

169 enrolled

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Prostatic Neoplasms

NCT00414765 2021-06-08

Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma

DermatologicGenitourinary

26 enrolled 7 charts

Carcinoma, Renal Cell, Melanoma

NCT01683188 2021-02-01

PROCLIVITY01

Phase 4 Terminated

53 enrolled

Melanoma, Skin Neoplasms

NCT04261179 2020-02-20

SENTINELSEEK

BreastDermatologicHead & Neck

30 enrolled

Breast Neoplasms, Head and Neck Neoplasms, Melanoma

NCT02451488 2020-02-10

Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma

8 enrolled 5 charts

Melanoma

NCT01898585 2020-01-07

An Open-Label Study of Zelboraf (Vemurafenib) in Patients With Braf V600 Mutation Positive Metastatic Melanoma

60 enrolled

Melanoma

NCT01053819 2018-02-23

Can We Miss Pigmented Lesions in Psoriasis Patients?

6 enrolled 3 charts